Sage Therapeutics, Inc. Contracts & Agreements
69 Contracts & Agreements
- Business Finance (17 contracts)
- Business Operations (6)
- Human Resources (21)
- Intellectual Property (6)
- Real Estate (10)
- Uncategorized (9)
- 2014 Employee Stock Purchase Plan, as amended (Filed With SEC on August 7, 2023)
- Supply Agreement by and between the Registrant and CyDex Pharmaceuticals, Inc., dated December 13, 2012, as amended August 21, 2013 and April 30, 2014 (Filed With SEC on August 7, 2023)
- Amendment No. 3 to Supply Agreement, by and between the Registrant and CyDex Pharmaceuticals, Inc., dated September 25, 2015 (Filed With SEC on August 7, 2023)
- Commercial License Agreement by and between the Registrant and CyDex Pharmaceuticals, Inc., dated August 21, 2013, as amended April 30, 2014 (Filed With SEC on August 7, 2023)
- Non-Exclusive License Agreement by and between the Registrant and the Regents of University of California, dated October 23, 2013, as amended May 14, 2014 (Filed With SEC on August 7, 2023)
- Exclusive License Agreement by and between the Registrant and Washington University, dated November 11, 2013 (Filed With SEC on August 7, 2023)
- Amended and Restated Non-Employee Director Compensation Policy, dated April 8, 2022 (Filed With SEC on August 2, 2022)
- 2014 Employee Stock Purchase Plan, as amended (Filed With SEC on August 2, 2022)
- Offer Letter by and between the Registrant and Christopher Benecchi, dated September 13, 2021 (Filed With SEC on November 2, 2021)
- Severance and Change in Control Agreement between the Registrant and Christopher Benecchi, dated September 13, 2021 (Filed With SEC on November 2, 2021)
- Amendment No. 1 to Exclusive License Agreement, by and between the Registrant and Washington University, dated as of July 13, 2021 (Filed With SEC on November 2, 2021)
- Side Letter to Biogen Collaboration and License Agreement, by and among the Registrant, Biogen MA Inc. and Biogen International GmbH, dated October 21, 2021 (Filed With SEC on November 2, 2021)
- Separation Agreement, by and between the Registrant and Michael Cloonan, dated March 12, 2021 (Filed With SEC on May 4, 2021)
- Form of Performance-Based Restricted Stock Unit Award Agreement Under the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan (Filed With SEC on August 10, 2020)
- Description of Securities (Filed With SEC on February 27, 2020)
- Eighth Amendment to Lease by and between ARE-MA Region No. 38, LLC and the Registrant, dated March 29, 2019 (Filed With SEC on August 6, 2019)
- Underwriting Agreement, dated as of February 25, 2019, by and among Sage Therapeutics, Inc. and Goldman Sachs & Co. LLC. and J.P. Morgan Securities LLC (Filed With SEC on February 27, 2019)
- Amended and Restated 2016 Inducement Equity Plan and forms of agreements thereunder, as amended and restated on September 20, 2018 (Filed With SEC on November 6, 2018)
- Amended and Restated Non-Employee Director Compensation Policy, dated as of September 20, 2018 (Filed With SEC on November 6, 2018)
- Seventh Amendment to Lease by and between ARE-MA Region No. 38, LLC and the Registrant, dated October 23, 2018 (Filed With SEC on November 6, 2018)
- First Amendment to Lease by and between CLPF-Cambridge Science Center LLC and the Registrant dated April 4, 2018 (Filed With SEC on May 3, 2018)
- Amended and Restated Non-Employee Director Compensation Plan, dated as of March 30, 2018 (Filed With SEC on May 3, 2018)
- Underwriting Agreement, dated as of February 8, 2018, among Sage Therapeutics, Inc. and J.P. Morgan Securities LLC, Goldman, Sachs & Co. LLC and Morgan Stanley & Co. LLC, as... (Filed With SEC on February 9, 2018)
- Underwriting Agreement, dated as of November 14, 2017, among Sage Therapeutics, Inc. and J.P. Morgan Securities LLC, Goldman, Sachs & Co. LLC and Morgan Stanley & Co. LLC, as... (Filed With SEC on November 15, 2017)
- Sage Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on November 2, 2017)
- Sixth Amendment to Lease by and between ARE-MA Region No. 38, LLC and the Registrant dated May 8, 2017 (Filed With SEC on August 3, 2017)
- 2014 Employee Stock Purchase Plan (Filed With SEC on August 3, 2017)
- Offer letter by and between the Registrant and Michael Cloonan, dated March 21, 2017 (Filed With SEC on August 3, 2017)
- Severance and Change in Control Agreement between the Registrant and Michael Cloonan, dated March 21, 2017 (Filed With SEC on August 3, 2017)
- SAGE Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 24, 2017)
- SAGETHERAPEUTICS, INC. 4,402,515 Shares of Common Stock Underwriting Agreement (thisAgreement) (Filed With SEC on September 9, 2016)
- THE CAMBRIDGE SCIENCE CENTER 245FIRST STREET CAMBRIDGE, MASSACHUSETTS 02142 LEASE SUMMARY SHEET (Filed With SEC on May 31, 2016)
- THE CAMBRIDGE SCIENCE CENTER 245FIRST STREET CAMBRIDGE, MASSACHUSETTS 02142 LEASE SUMMARY SHEET (Filed With SEC on May 31, 2016)
- Sage Therapeutics (Filed With SEC on May 3, 2016)
- FIFTH AMENDMENT TO LEASE (Filed With SEC on February 29, 2016)
- SAGETHERAPEUTICS, INC. 3,157,894 Shares of Common Stock Underwriting Agreement (thisAgreement) (Filed With SEC on January 7, 2016)
- AMENDED AND RESTATED COMMERCIAL LICENSE AGREEMENT (Filed With SEC on November 6, 2015)
- AMENDMENT NO. 3 TO SUPPLY AGREEMENT (Filed With SEC on November 6, 2015)
- THIRD AMENDMENT TO LEASE (Filed With SEC on November 6, 2015)
- FOURTH AMENDMENT TO LEASE (Filed With SEC on November 6, 2015)
- EXCLUSIVE LICENSE AGREEMENT BETWEEN SAGETHERAPEUTICS, INC. AND THE REGENTS OF THE UNIVERSITY OF CALIFORNIA FOR NEUROSTEROIDS ANDTHEIR USE IN SEIZURES AND TRAUMATIC BRAIN INJURY UC... (Filed With SEC on August 12, 2015)
- SAGE THERAPEUTICS, INC. [] Shares of Common Stock Underwriting Agreement (this Agreement) (Filed With SEC on April 13, 2015)
- SEVERANCE AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on March 6, 2015)
- SEVERANCE AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on March 6, 2015)
- SEVERANCE AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on March 6, 2015)
- SEVERANCE AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on March 6, 2015)
- SEVERANCE AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on March 6, 2015)
- SAGE THERAPEUTICS, INC. [] Shares of Common Stock Underwriting Agreement (this Agreement) (Filed With SEC on July 8, 2014)
- SECOND AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on July 8, 2014)
- SAGE THERAPEUTICS, INC. 2011 STOCK OPTION AND GRANT PLAN (Filed With SEC on July 8, 2014)
- SAGE THERAPEUTICS, INC. 2014 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on July 8, 2014)
- ***Text Omitted and Filed Separately with the Securities and Exchange Commission Confidential Treatment Requested Under 17 C.F.R. Sections200.80(b)(4) and 230.406 EXCLUSIVE... (Filed With SEC on July 8, 2014)
- ***Text Omitted and Filed Separately with the Securities and Exchange Commission Confidential Treatment Requested Under 17 C.F.R. Sections200.80(b)(4) and 230.406 COMMERCIAL... (Filed With SEC on July 8, 2014)
- ***Text Omitted and Filed Separately with the Securities and Exchange Commission Confidential Treatment Requested Under 17 C.F.R. Sections200.80(b)(4) and 230.406 Non-Exclusive... (Filed With SEC on July 8, 2014)
- LEASE AGREEMENT (Filed With SEC on July 8, 2014)
- Sage Therapeutics, Inc. (Filed With SEC on July 8, 2014)
- Sage Therapeutics, Inc. (Filed With SEC on July 8, 2014)
- Sage Therapeutics, Inc. (Filed With SEC on July 8, 2014)
- SAGE THERAPEUTICS, INC. Employee Non-Competition, Non-Solicitation, Confidentiality and Assignment Agreement (Filed With SEC on July 8, 2014)
- SAGE THERAPEUTICS, INC. Employee Non-Competition, Non-Solicitation, Confidentiality and Assignment Agreement (Filed With SEC on July 8, 2014)
- SAGE THERAPEUTICS, INC. Employee Non-Competition, Non-Solicitation, Confidentiality and Assignment Agreement (Filed With SEC on July 8, 2014)
- SAGE THERAPEUTICS, INC. Employee Non-Competition, Non-Solicitation, Confidentiality and Assignment Agreement (Filed With SEC on July 8, 2014)
- SAGE THERAPEUTICS, INC. SENIOR EXECUTIVE CASH INCENTIVE BONUS PLAN (Filed With SEC on July 8, 2014)
- SAGE THERAPEUTICS, INC. FORM OF DIRECTOR INDEMNIFICATION AGREEMENT (Filed With SEC on July 8, 2014)
- SAGE THERAPEUTICS, INC. FORM OF OFFICER INDEMNIFICATION AGREEMENT (Filed With SEC on July 8, 2014)
- ***Text Omitted and Filed Separately with the Securities and Exchange Commission Confidential Treatment Requested Under 17 C.F.R. Sections200.80(b)(4) and 230.406 SUPPLY AGREEMENT (Filed With SEC on July 8, 2014)
- SAGE THERAPEUTICS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on July 8, 2014)
- P ###-###-#### F ###-###-#### 215 First Street, Cambridge, MA 02142 (Filed With SEC on July 8, 2014)
- SEVERANCE AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on July 8, 2014)